- Retinal imaging device company Optos has initiated a $16-million collaboration to develop cutting-edge optical imaging technology with the National Health Services (NHS) of Glasgow and Clyde, as well as the universities of Kent and Strathclyd.
- The first studies will focus on age-related macular degeneration, glaucoma and diabetic retinopathy.
- The goal is to develop a medical imaging device that could allow earlier detection of diseases that lead to blindness by 2018.
This is a perfect example of corporate-governmental-academic collaboration and represents a new framework for collaborative ventures going forward in the UK. The underlying clinical reality driving this research is that early intervention in many ophthalmic diseases can change outcomes.